PAIN TRIGGERS
Nationwide shortage of Teva generic Adderall leaving pharmacies empty.
Manufacturer headquarters proximity does not allow direct access to medication for individuals.
SaaS· ADHD patients prescribed stimulant medicationPain 7.00/10WTP 6.0/10Market 7.0/10Validation 8.0Confidence 72%May 5, 2026
TevaStock: Crowdsourced Real-Time Pharmacy Locator for Teva Adderall
Nationwide Teva generic Adderall shortages leave pharmacies empty, forcing patients to waste hours searching for stock with no centralized visibility.
automationchronic-conditionhealthcaremedication-managementmobile-apppatientsproductivitysaas
1
STAGE 01 · PROBLEM
Is the problem real?
CANONICAL PROBLEM
ADHD patients face nationwide shortages of preferred generic Adderall (Teva), making it extremely difficult to fill prescriptions at pharmacies.
FREQUENCY
Multiple repeated complaints in the post and comments.
INTENSITY
Users explicitly describe existing tools as bloated/overkill and mention workaround behavior.
EVIDENCE
The manufacturer of generic brand Teva is a 3 minute drive from my house
ADHD11
The manufacturer of generic brand Teva is a 3 minute drive from my house
ADHD11
2
STAGE 02 · CUSTOMER
Who feels this pain?
TARGET USERS
ADHD patients prescribed stimulant medicationA D H D Patients On Teva Generic Adderall
Adults and parents managing ADHD who rely on the specific Teva generic version of Adderall and need to fill prescriptions monthly during ongoing nationwide shortages.
Context
Obtain prescribed Teva generic Adderall medication reliably during a shortage.
Spending extended time calling multiple pharmacies to locate stock.
Calling the manufacturer directly for shortage updates.
Current Workarounds
Spending 45+ minutes calling multiple pharmacies daily
Checking manufacturer shortage updates by phone
Driving between pharmacies hoping for stock
3
STAGE 03 · MARKET
Where's the gap?
EXISTING SOLUTION GAPS
Pharmacy searches take significant time with no stock available.
Manufacturer provides shortage information but cannot supply directly to patients.
No direct consumer channel for medication during shortages.
OPPORTUNITY & VALUE
Why Now
Strong repeated nationwide shortage complaints with dedicated megathread and multiple users describing time-consuming searches.
Value Proposition
Hyper-focused on Teva Adderall shortages with patient-verified reports vs generic price tools or broad pharmacy apps.
Product Direction
Community-powered mobile app where verified patients report real-time Teva Adderall availability at local pharmacies, with alerts and maps to nearest stocked locations.
4
STAGE 04 · BUSINESS
How does it make money?
MONETIZATION
$9/moPremium alerts and priority reports
Model
Freemium SaaS
WILLINGNESS TO PAY
Patients already invest hours weekly calling pharmacies and express desperation over shortages; a low-cost tool saving even 2-3 hours/month justifies the fee as it directly reduces stress and missed doses.
5
STAGE 05 · EXECUTION
How do you ship it?
MVP PLAN
“Find Teva Adderall stock in your area within minutes instead of hours.”
Community-powered mobile app where verified patients report real-time Teva Adderall availability at local pharmacies, with alerts and maps to nearest stocked locations.
Core Features
User-reported pharmacy stock checker with verification
Location-based search and push alerts for stock
Shortage status dashboard pulled from official sources
Weekly Roadmap
1
W1-W2
Basic reporting and map UI ready for single-city testing.
- •Build user authentication and pharmacy search form
- •Create simple report submission with location
- •Static map view of reports
2
W3-W4
Real-time feed and alerts functional for beta users.
- •Implement report moderation queue
- •Add push notifications for stock in area
- •Integrate basic official shortage API/data
3
W5
Internal testing with 20-30 ADHD users and polish.
- •Recruit beta testers from Reddit threads
- •Add report verification flow
- •UI/UX fixes based on feedback
4
W6
Public beta launch with first premium signups.
- •Stripe integration for premium tier
- •Post in key ADHD subreddits
- •Track usage metrics and first conversions
Launch Strategy
Launch in r/ADHD, r/ADHDers, and shortage megathreads on Reddit plus targeted Facebook groups for ADHD support.
RISKS & ASSUMPTIONS
Top Risks
Regulatory and legal exposure
Handling information on controlled substances risks FDA/DEA scrutiny or claims of facilitating access improperly.
Data accuracy and verification
Unverified user reports could lead to wasted trips and loss of trust in the platform.
Critical mass for reports
Sparse early user base means low coverage outside major cities, limiting value.
User verification challenges
Ensuring reporters are legitimate patients without exposing sensitive health data.
6
STAGE 06 · DECISION
Should you build it?
NEED A CLEARER CALL?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This idea scores in the upper-middle range of opportunities surfaced by MonetScope, with a validation sub-score of 8/10 against 2 independently sourced evidence signals. A "promising" rating usually indicates a real pain has been detected and discussed in the open, but the pipeline did not find enough signal to flag it as urgent or high-frequency. These opportunities can still produce excellent businesses — they often correspond to "boring" problems that established players have ignored — but the founder should expect a longer customer-development cycle to confirm willingness to pay.
Why this matters for SaaS founders
It sits at the intersection of "automation", "chronic-condition", "healthcare", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "TevaStock: Crowdsourced Real-Time Pharmacy Locator for Teva Adderall" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for automation?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.